1. Home
  2. SLNO vs DNP Comparison

SLNO vs DNP Comparison

Compare SLNO & DNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • DNP
  • Stock Information
  • Founded
  • SLNO 1999
  • DNP 1986
  • Country
  • SLNO United States
  • DNP United States
  • Employees
  • SLNO N/A
  • DNP N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • DNP Investment Managers
  • Sector
  • SLNO Health Care
  • DNP Finance
  • Exchange
  • SLNO Nasdaq
  • DNP Nasdaq
  • Market Cap
  • SLNO 3.8B
  • DNP 3.7B
  • IPO Year
  • SLNO 2014
  • DNP N/A
  • Fundamental
  • Price
  • SLNO $49.71
  • DNP $9.91
  • Analyst Decision
  • SLNO Strong Buy
  • DNP
  • Analyst Count
  • SLNO 10
  • DNP 0
  • Target Price
  • SLNO $112.50
  • DNP N/A
  • AVG Volume (30 Days)
  • SLNO 1.7M
  • DNP 479.6K
  • Earning Date
  • SLNO 11-05-2025
  • DNP 01-01-0001
  • Dividend Yield
  • SLNO N/A
  • DNP 7.88%
  • EPS Growth
  • SLNO N/A
  • DNP N/A
  • EPS
  • SLNO N/A
  • DNP 2.30
  • Revenue
  • SLNO $32,656,999.00
  • DNP $154,887,179.00
  • Revenue This Year
  • SLNO N/A
  • DNP N/A
  • Revenue Next Year
  • SLNO $175.39
  • DNP N/A
  • P/E Ratio
  • SLNO N/A
  • DNP $4.26
  • Revenue Growth
  • SLNO N/A
  • DNP 3.30
  • 52 Week Low
  • SLNO $41.50
  • DNP $8.69
  • 52 Week High
  • SLNO $90.32
  • DNP $10.04
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 22.26
  • DNP 52.32
  • Support Level
  • SLNO $50.63
  • DNP $9.92
  • Resistance Level
  • SLNO $72.99
  • DNP $10.04
  • Average True Range (ATR)
  • SLNO 4.32
  • DNP 0.08
  • MACD
  • SLNO -1.60
  • DNP 0.01
  • Stochastic Oscillator
  • SLNO 3.34
  • DNP 48.08

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About DNP DNP Select Income Fund Inc.

DNP Select Income Fund Inc is a closed-ended investment management fund. The primary investment objectives of the fund are current income and long-term growth of income. Its secondary objective is capital appreciation. The Fund seeks to achieve its investment objectives by investing in the public utility industry.

Share on Social Networks: